Filing Details
- Accession Number:
- 0000905148-24-000061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-03 19:25:23
- Reporting Period:
- 2024-01-01
- Accepted Time:
- 2024-01-03 19:25:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1704292 | Zai Lab Ltd | ZLAB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1835824 | Harald Reinhart | C/O Zai Lab Limited 314 Main Street, 4Th Floor, Suite 100 Cambridge MA 02142 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Acquisiton | 2024-01-01 | 17,548 | $0.00 | 50,863 | No | 4 | M | Direct | |
| American Depositary Shares | Disposition | 2024-01-03 | 4,803 | $26.12 | 46,060 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| American Depositary Shares | Performance-Based Share Units | Acquisiton | 2024-01-01 | 17,548 | $0.00 | 17,548 | $0.00 |
| American Depositary Shares | Performance-Based Share Units | Disposition | 2024-01-01 | 17,548 | $0.00 | 17,548 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 17,548 | No | 4 | A | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
- ADSs acquired on vesting of performance-based share units (PSUs). Each ADS represents ten Ordinary Shares of the issuer.
- Each PSU represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer.
- These ADSs were sold automatically to cover taxes upon vesting of PSUs.
- The reporting person was granted PSUs on December 1, 2021 that vest based on the satisfaction of specified performance criteria between December 1, 2021 and December 31, 2025. On January 1, 2024, the performance-based vesting conditions were confirmed for PSUs representing 17,548 ADSs.
Billionaire Hedge Funds
